Cargando…

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer that lacks expression of estrogen receptor (ER) and progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) gene. Chemotherapy remains the standard of care for TNBC treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ruishan, Li, Xiang, Liu, Zhuangkai, Wang, Yuying, Zhang, Hao, Xu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236314/ https://www.ncbi.nlm.nih.gov/pubmed/32477007 http://dx.doi.org/10.1186/s12935-020-01260-5

Ejemplares similares

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
por: Weihua, Zeng, et al.
Publicado: (2020)

RNF181 modulates Hippo signaling and triple negative breast cancer progression
por: Zhou, Rui, et al.
Publicado: (2020)

Roles of eIF3m in the tumorigenesis of triple negative breast cancer
por: Han, Wei, et al.
Publicado: (2020)

Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells
por: Jin, Mengyuan, et al.
Publicado: (2021)

Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer
por: Ting, Chen-Hung, et al.
Publicado: (2016)

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018)

The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes
por: Li, Xiang, et al.
Publicado: (2017)

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition
por: Elango, Ramesh, et al.
Publicado: (2021)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer
por: Huang, Yajing, et al.
Publicado: (2020)

Expression and potential role of FOSB in glioma
por: Qi, Min, et al.
Publicado: (2022)

The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2
por: Sun, Dan, et al.
Publicado: (2020)

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer
por: Zhang, Purong, et al.
Publicado: (2020)

MicroRNA-325 targets lipocalin 15 to suppress proliferation, migration and invasion of breast cancer cells
por: Liu, Zhuangkai, et al.
Publicado: (2020)

ZMIZ2 promotes the development of triple-receptor negative breast cancer
por: Zou, Xiaopan, et al.
Publicado: (2022)

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
por: Shi, Zhendong, et al.
Publicado: (2017)

Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2
por: Guo, Jianping, et al.
Publicado: (2018)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
por: Ramaglia, Maria, et al.
Publicado: (2016)

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
por: Xi, Yue, et al.
Publicado: (2022)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
por: Chung, Alexander H., et al.
Publicado: (2019)

Hydrogen inhibits the proliferation and migration of gastric cancer cells by modulating lncRNA MALAT1/miR-124-3p/EZH2 axis
por: Zhu, Baocheng, et al.
Publicado: (2021)

Repeated 6-Hz Corneal Stimulation Progressively Increases FosB/ΔFosB Levels in the Lateral Amygdala and Induces Seizure Generalization to the Hippocampus
por: Giordano, Carmela, et al.
Publicado: (2015)

Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB–VCAM-1 axis
por: Li, Yue, et al.
Publicado: (2020)

LNK promotes the growth and metastasis of triple negative breast cancer via activating JAK/STAT3 and ERK1/2 pathway
por: Lv, Jianxin, et al.
Publicado: (2020)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
por: Yi, Dandan, et al.
Publicado: (2019)

Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells
por: Wu, Jia-Yan, et al.
Publicado: (2021)

Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)

Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India
por: Rehman, Asad Ur, et al.
Publicado: (2020)

LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2
por: Zhang, Shuyao, et al.
Publicado: (2020)

Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
por: Yu, Yong, et al.
Publicado: (2019)

SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression
por: Wang, Lu, et al.
Publicado: (2013)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
por: Li, Yang, et al.
Publicado: (2020)

Recurrent rearrangements of FOS and FOSB define osteoblastoma
por: Fittall, Matthew W., et al.
Publicado: (2018)

Suboptimal concordance in testing and retesting results of triple-negative breast carcinoma cases among laboratories: one institution experience
por: De Jesus, Jose, et al.
Publicado: (2019)

Opiate Sensitization Induces FosB/ΔFosB Expression in Prefrontal Cortical, Striatal and Amygdala Brain Regions
por: Kaplan, Gary B., et al.
Publicado: (2011)

Glucocorticoids Regulation of FosB/ΔFosB Expression Induced by Chronic Opiate Exposure in the Brain Stress System
por: García-Pérez, Daniel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bdsisa3gjb9p2sd816tsdo96b3